Related Experiment Videos
Profiling treatment-specific post-translational modifications in a complex proteome with subtractive substrate phage
Angela Tenzer1, Barbara Hofstetter, Christelle Sauser
1Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
Proteomics
|September 8, 2004
Summary
Researchers developed a new method to identify treatment-induced protein modifications. This technique aids in discovering new drug targets by finding specific enzyme substrates in complex biological samples.
Area of Science:
- Biochemistry
- Molecular Biology
- Proteomics
Background:
- Post-translational modifications regulate cellular stress responses.
- Identifying substrates of enzymes with altered activity is crucial for drug discovery.
- Targeting treatment-induced modifications offers a novel therapeutic strategy.
Purpose of the Study:
- To present a novel subtractive substrate phage display screening method.
- To select treatment-induced post-translational peptide modifications in complex proteomes.
- To identify and validate novel peptide substrates for drug discovery.
Main Methods:
- Subtractive and iterative phage display screening of cellular extracts.
- Utilized tumor cells treated with a protease-activating anticancer therapy.
- Distinguished specific substrates from background proteolytic activity.
Main Results:
- Identified specific phages acting as substrates for treatment-induced proteolytic activities.
- Successfully differentiated treatment-specific substrates from non-specific ones.
- Validated novel peptide substrates in vitro and in vivo, demonstrating specificity and biological significance.
Conclusions:
- The developed subtractive substrate phage display is effective for identifying treatment-induced proteolytic modifications.
- Novel peptide substrates identified have high specificity and biological relevance.
- This method facilitates the prioritization and validation of drug discovery targets.